Arantes D, Costa N, Resende T, Mikulas K, Júnior PD, Brito R, Noronha V, Pedras R, Corrêa L. Dental approach of orofacial pain in head and neck cancer patients. J Clin Exp Dent. 2018;10(11):e1082-90.

doi:10.4317/jced.55311

http://dx.doi.org/doi:10.4317/jced.55311

References

1. Zevallos JP. International Head and Neck Cancer Epidemiology Consortium: Update No. 21. Head & Neck. 2016;38:1447-1448. https://doi.org/10.1002/hed.24552

2. Epstein JB, Hong C, Logan RM, Barasch A, Gordon SM, Oberle-Edwards L, et al. A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer. 2010;18:1023-1031. https://doi.org/10.1007/s00520-010-0897-7 PMid:20544225

3. Zakrzewska JM. Differential diagnosis of facial pain and guidelines for management. British Journal of Anaesthesia. 2013;111:95–104. https://doi.org/10.1093/bja/aet125 PMid:23794651

4. Sigley C. Cancer Pain: A Concept Analysis. International Journal of Healthcare Sciences. 2016;4:71-7.

5. Oliveira KG, von Zeidler SV, Podestá JR, Sena A, Souza ED, Lenzi J, et al. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplasic therapy. BMC Cancer. 2014;14:2-8.

6. Scrivani SJ, Spierings ELH. Classification and Differential Diagnosis of Oral and Maxillofacial Pain. Oral Maxillofacial Surg Clin N Am. 2016;28:233–46. https://doi.org/10.1016/j.coms.2016.04.003 PMid:27475504

7. Shephard MK, Macgregor EA, Zakrzewska JM. Orofacial pain: a guide for the headache physician. Headache. 2014;54:22-39. https://doi.org/10.1111/head.12272 PMid:24261452

8. Sonis ST, Villa A. Phase II investigational oral drugs for the treatment of radio/chemotherapy induced oral mucositis. Expert Opin Investig Drugs. 2018;27:147-54. https://doi.org/10.1080/13543784.2018.1427732 PMid:29323575

9. Heijnen BJ, Speyer R, Kertscher B, Cordier R, Koetsenruijter KW, Swan K, et al. Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature. Bio Med Research International. 2016;2016:6086894. https://doi.org/10.1155/2016/6086894 PMid:27722170 PMCid:PMC5045989

10. Feller L, Fourie J, Bouckaert M, Khammissa RAG, Ballyram R, Lemmer J. Burning Mouth Syndrome: Aetiopathogenesis and Principles of Management. Pain Research and Management. 2017;2017:1926269.

11. Schestatsky P, Torres VF, Chaves MLF, Ehlers BC, Mucenic T, Caumo W, et al. Brazilian portuguese validation of the leeds assessment of neuropathic symptoms and signs for patients with chronic pain. Pain Med. 2011;12:1544-1550. https://doi.org/10.1111/j.1526-4637.2011.01221.x PMid:21883875

12. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45-56. https://doi.org/10.1016/0304-3959(83)90126-4

13. Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain. 2003;4:2-21. https://doi.org/10.1054/jpai.2003.1 PMid:14622723

14. Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003;4:407-414. https://doi.org/10.1016/S1526-5900(03)00716-8

15. Shiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Networkand Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28:6–27. https://doi.org/10.11607/jop.1151* PMid:24482784 PMCid:PMC4478082

16. Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement. Crit Rev Oncol Hematol. 2016;97:131-42 https://doi.org/10.1016/j.critrevonc.2015.08.010 PMid:26318095

17. Hong CHL, Hu S, Haverman T, Stokman M, Nape-as JJ, Braber JB, et al. A systematic review of dental disease management in cancer patients. Support Care Cancer. 2018;26:155-174. https://doi.org/10.1007/s00520-017-3829-y PMid:28735355

18. Al-Bazie SA, Bahatheq M, Al-Ghazi M, Al-Raihi N, Ramalingam S. Antibiotic protocol for the prevention of osteoradionecrosis following dental extractions in irradiated head and neck cancer patients: A 10 years prospective study. J Cancer Res Ther. 2016;12:565-70. https://doi.org/10.4103/0973-1482.159090 PMid:27461611

19. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, et al. Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer. 2016;24:2793-805. https://doi.org/10.1007/s00520-016-3153-y PMid:26984249 PMCid:PMC4846551

20. Furlan RMMM, Giovanardi RS, Britto ATBO, Britto DBO. The use of superficial heat for treatment of temporomandibular disorders: an integrative review. CoDAS. 2015;27:207-12. https://doi.org/10.1590/2317-1782/20152014148 PMid:26107088

21. World Health Organization. Traitement de la douleur cancéreuse. Geneva, Switz: World Health Organization; 1997.

22. Buglione M, Cavagnini R, Di Rosario F, Maddalo M, Vassalli L, Grisanti S et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement. Crit Rev Oncol Hematol. 2016;102:47-54. https://doi.org/10.1016/j.critrevonc.2016.03.012 PMid:27061883

23. Machado E, Machado P, Wandscher VF, Marchionatti AME, Zanatta FB, Kaizer OB. A systematic review of different substance injection and dry needling for treatment of temporomandibular myofascial pain. Int J Oral Maxillofac Surg. 2018;47:1420-1432. PMid:29801994

24. Perdomo S, Martin Roa G, Brennan P, Forman D, Sierra MS. Head and neck cancer burden and preventive measures in Central and South America. Cancer Epidemiol. 2016;Suppl1:S43-S52. https://doi.org/10.1016/j.canep.2016.03.012 PMid:27678322

25. Schuurhuis JM, Stokman MA, Witjes MJ, Langendijk JA, van Winkelhoff AJ, Vissink A et al. Head and neck intensity modulated radiation therapy leads to an increase of opportunistic oral pathogens. Oral Oncol. 2016;58:32-40. https://doi.org/10.1016/j.oraloncology.2016.05.005 PMid:27311400

26. Deng J, Jackson L, Epstein JB, Migliorati CA, Murphy BA. Dental demineralization and caries in patients with head and neck cancer. Oral Oncol. 2015;51:824-31. https://doi.org/10.1016/j.oraloncology.2015.06.009 PMid:26198979

27. Yokota T, Tachibana H, Konishi T, Yurikusa T, Hamauchi S, Sakai K et al. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy. Support Care Cancer. 2016;24:3029-36. https://doi.org/10.1007/s00520-016-3122-5

28. Romero-Reyes M, Salvemini D. Cancer and orofacial pain. Med Oral Patol Oral Cir Bucal. 2016;1:e665-e671. https://doi.org/10.4317/medoral.21515

29. Wilkie DJ, Huang H-Y, Reilly NL. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage. 2001;22:899–910. https://doi.org/10.1016/S0885-3924(01)00351-7

30. Ferreira AM, de Souza Lucena EE, de Oliveira TC, da Silveira É, de Oliveira PT, de Lima KC. Prevalence and factors associated with oral potentially malignant disorders in Brazil's rural workers. Oral Disease. 2016;22:536-54. https://doi.org/10.1111/odi.12488 PMid:27090966